BIOMAT Database Logo BIOMAT Database Logo

Structure-activity relationships of analogues of NF449 confirm NF449 as the most potent and selective known P2X1 receptor antagonist. 2004

Matthias U Kassack, and Kirsten Braun, and Matthias Ganso, and Heiko Ullmann, and Peter Nickel, and Barbara Böing, and Gregor Müller, and Günter Lambrecht
Pharmaceutical Institute, University of Bonn, An der Immenburg 4, 53121 Bonn, Germany. kassack@uni-bonn.de

NF449 [4,4',4",4"'-(carbonylbis(imino-5,1,3-benzenetriyl-bis(carbonylimino)))tetrakisbenzene-1,3-disulfonic acid-octasodiumsalt)] was recently described to inhibit recombinant rP2X(1) receptors (Naunyn Schmiedeberg's Arch. Pharmacol. 364 (2001) 285). The purpose of this study was to examine structure-activity-relationships at P2 receptors of a series of NF449 analogues. Thus, compounds containing various arylaminemono-, di-, or trisulfonic acids and a replacement of the central urea bridge were synthesized. NF449 displayed a pIC(50) at P2X(1) receptors (rat vas deferens) of 6.31 +/- 0.04 being at least 19-fold more potent at P2X(1) than at P2X(3), P2Y(1), P2Y(2), or P2Y(11). Any deletion or change of position of sulfonic acid groups or replacing the central urea bond by the bisamide of terephthalic acid reduced the potency at P2X(1) by at least 90%. All compounds were very weak antagonists at P2Y(2) or P2Y(11) receptors (pIC(50) < 4.5). In conclusion, NF449 remains the most potent and selective P2X(1) antagonist known. Potential lead compounds among the suramin class for P2X(3) (16d) and P2Y(1) (16a) receptors were identified.

UI MeSH Term Description Entries
D007082 Ileum The distal and narrowest portion of the SMALL INTESTINE, between the JEJUNUM and the ILEOCECAL VALVE of the LARGE INTESTINE.
D007928 Lethal Dose 50 The dose amount of poisonous or toxic substance or dose of ionizing radiation required to kill 50% of the tested population. LD50,Dose 50, Lethal
D008297 Male Males
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000255 Adenosine Triphosphate An adenine nucleotide containing three phosphate groups esterified to the sugar moiety. In addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter. ATP,Adenosine Triphosphate, Calcium Salt,Adenosine Triphosphate, Chromium Salt,Adenosine Triphosphate, Magnesium Salt,Adenosine Triphosphate, Manganese Salt,Adenylpyrophosphate,CaATP,CrATP,Manganese Adenosine Triphosphate,MgATP,MnATP,ATP-MgCl2,Adenosine Triphosphate, Chromium Ammonium Salt,Adenosine Triphosphate, Magnesium Chloride,Atriphos,Chromium Adenosine Triphosphate,Cr(H2O)4 ATP,Magnesium Adenosine Triphosphate,Striadyne,ATP MgCl2
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001557 Benzenesulfonates Organic salts and esters of benzenesulfonic acid.

Related Publications

Matthias U Kassack, and Kirsten Braun, and Matthias Ganso, and Heiko Ullmann, and Peter Nickel, and Barbara Böing, and Gregor Müller, and Günter Lambrecht
Structure-activity relationships of pyridoxal phosphate derivatives as potent and selective antagonists of P2X1 receptors.
February 2001, Journal of medicinal chemistry,
Matthias U Kassack, and Kirsten Braun, and Matthias Ganso, and Heiko Ullmann, and Peter Nickel, and Barbara Böing, and Gregor Müller, and Günter Lambrecht
Discovery and Structure Relationships of Salicylanilide Derivatives as Potent, Non-acidic P2X1 Receptor Antagonists.
June 2020, Journal of medicinal chemistry,
Matthias U Kassack, and Kirsten Braun, and Matthias Ganso, and Heiko Ullmann, and Peter Nickel, and Barbara Böing, and Gregor Müller, and Günter Lambrecht
Zatosetron, a potent, selective, and long-acting 5HT3 receptor antagonist: synthesis and structure-activity relationships.
January 1992, Journal of medicinal chemistry,
Matthias U Kassack, and Kirsten Braun, and Matthias Ganso, and Heiko Ullmann, and Peter Nickel, and Barbara Böing, and Gregor Müller, and Günter Lambrecht
Structure-Activity Relationships of Cinnamate Ester Analogues as Potent Antiprotozoal Agents.
January 2020, ChemMedChem,
Matthias U Kassack, and Kirsten Braun, and Matthias Ganso, and Heiko Ullmann, and Peter Nickel, and Barbara Böing, and Gregor Müller, and Günter Lambrecht
Structure-activity relationships of piperazinebenzylamines as potent and selective agonists of the human melanocortin-4 receptor.
September 2004, Bioorganic & medicinal chemistry letters,
Matthias U Kassack, and Kirsten Braun, and Matthias Ganso, and Heiko Ullmann, and Peter Nickel, and Barbara Böing, and Gregor Müller, and Günter Lambrecht
Structure-activity relationship studies of spinorphin as a potent and selective human P2X(3) receptor antagonist.
September 2007, Journal of medicinal chemistry,
Matthias U Kassack, and Kirsten Braun, and Matthias Ganso, and Heiko Ullmann, and Peter Nickel, and Barbara Böing, and Gregor Müller, and Günter Lambrecht
Synthesis and structure-activity relationships of TAN-1511 analogues as potent hematopoietic agents.
February 1998, Chemical & pharmaceutical bulletin,
Matthias U Kassack, and Kirsten Braun, and Matthias Ganso, and Heiko Ullmann, and Peter Nickel, and Barbara Böing, and Gregor Müller, and Günter Lambrecht
Synthesis and quantitative structure-activity relationships of N-(1-benzylpiperidin-4-yl)phenylacetamides and related analogues as potent and selective sigma1 receptor ligands.
June 1998, Journal of medicinal chemistry,
Matthias U Kassack, and Kirsten Braun, and Matthias Ganso, and Heiko Ullmann, and Peter Nickel, and Barbara Böing, and Gregor Müller, and Günter Lambrecht
Combined tachykinin receptor antagonist: synthesis and stereochemical structure-activity relationships of novel morpholine analogues.
August 2000, Bioorganic & medicinal chemistry letters,
Matthias U Kassack, and Kirsten Braun, and Matthias Ganso, and Heiko Ullmann, and Peter Nickel, and Barbara Böing, and Gregor Müller, and Günter Lambrecht
Chiral analogues of (+)-cyclazosin as potent α1B-adrenoceptor selective antagonist.
July 2018, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!